[Histopathological study on the process of joint destruction in rheumatoid arthritis].
Itoh
Yoshitaka
Y
Department of Orthopedic Surgery, Jikei University School of Medicine.
Takahashi
Yukihiro
Y
Sawai
Takashi
T
D000844:Ankylosis / Q000473:pathology; D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000473:pathology*; D002061:Bursa, Synovial / Q000276:immunology / Q000473:pathology; D002352:Carrier Proteins / Q000502:physiology; D002358:Cartilage, Articular / Q000378:metabolism / Q000473:pathology; D002403:Cathepsins / Q000096:biosynthesis; D016207:Cytokines / Q000502:physiology; D005109:Extracellular Matrix / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D007596:Joints / Q000276:immunology / Q000473:pathology*; D008214:Lymphocytes / Q000276:immunology / Q000473:pathology; D020782:Matrix Metalloproteinases / Q000096:biosynthesis; D008562:Membrane Glycoproteins / Q000502:physiology; D011509:Proteoglycans / Q000378:metabolism; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D013583:Synovial Membrane / Q000276:immunology / Q000378:metabolism / Q000473:pathology
D002352:Carrier Proteins; D016207:Cytokines; D006025:Glycosaminoglycans; D008562:Membrane Glycoproteins; D011509:Proteoglycans; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; D002403:Cathepsins; D020782:Matrix Metalloproteinases